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Abstract 
Background: Opioid addiction causes many preventable deaths across the United States. Many 
recommendations to prevent opioid addiction have been made, however, many recommendations 
have not been fully evaluated for efficacy. This has led to a gap in knowledge for providers and 
healthcare systems to make informed decisions on how to reduce opioid addiction.  
Objectives: This study explores different prescriber-based opioid prevention strategies, 
providing an analysis and ranking for the strategies that most effectively reduce opioid abuse and 
exposure. Additionally, the analysis provides recommendations for future research.  
Methods: An integrative literature review was conducted to investigate three opioid abuse 
prevention strategies: prescription drug monitoring programs, physician continuing education, 
and risk assessment screening tools. Information has been organized according to prevention 
strategy type and presented in a data matrix table. 
Results: Most studies (4 out of 5) that examined risk assessment screening tool concluded that 
their use resulted in statistically significant reductions in opioid abuse.  Prescription drug 
monitoring programs had more mixed results but overall resulted in modest reductions. 
Physician continuing education resulted in very few statistically significant outcomes.  
Discussion: The opioid abuse prevention strategies have the greatest to the least impact in the 
following order 1) risk assessment screening tools 2) prescription drug monitoring programs, and 
3) prescriber continuing education. 
Keywords: Opioids, opioid abuse prevention, opioid addiction prevention, prescription drug 
monitoring programs, physician continuing education, risk assessment screening tool, risk 
assessment questionnaire, opioid abuse prevention strategies 
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A Comparison of Prescriber-Based Opioid Addiction Prevention Strategies:  
An Integrative Literature Review 
Introduction 
Opioid addiction can be seen on the streets, in the emergency room and even in pictures 
posted on social media. In 2017, police officers of East Liverpool, Ohio posted a very graphic 
and controversial picture on social media as a cry for help (Park, 2017). In the picture, a young 
boy stares blankly at the camera while his two caregivers are unconscious from a heroin 
overdose in the front seat of their car. The picture is a haunting representation of the current 
United States opioid addiction epidemic. According to the Center for Disease Control and 
Prevention (2016), “deaths from prescription opioids—drugs like oxycodone, hydrocodone, and 
methadone—have more than quadrupled since 1999” (Understanding the Epidemic section, para. 
1). Additionally, the CDC reports that 91 Americans die from opioids every day. The epidemic 
affects so many people that the use of NARCAN (an opioid antagonist) is now taught at basic 
provider level CPR classes. 
This is an epidemic that affects people throughout the lifespan and across all 
demographic variables. According to Richter, Kunz, & Foster (2015), since 2010, opioids are the 
leading cause of death in people between the ages of 12 years old and 50 years old, affecting 
older adults and adolescents as well. Additionally, the National Center on Addiction and 
Substance Abuse (NCASA, 2017) reports that “opioid related deaths have risen across virtually 
all demographic groups and in almost every state in the nation” (pg. 4). Illinois alone has lost 
over 11,000 people to the opioid epidemic since 2008 with projections of the loss of nearly 3,000 
more lives by the year 2020 (State of Illinois, 2017). 
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In addition to the fact that the opioid epidemic has a profound impact on different 
demographics and causes many preventable deaths, it also represents a huge cost. The NCASA 
(2017) estimates that states spend an average of nearly sixteen percent of their budget combating 
substance abuse and addiction, with that spending being primarily on consequences rather than 
prevention. Other economists have estimated that paying for one year of costs related to the 
opioid epidemic exceeds 78.5 billion dollars (Florence, Xu, & Zhou, 2016). 
 This epidemic carries very meaningful implications for healthcare industry professionals. 
Healthcare providers have worsened the situation according to many studies. “Opioid addiction 
can actually begin with a trip to the emergency room. A wide variation in rates of opioid 
prescribing existed among physicians practicing within the same emergency department, and 
rates of long-term opioid use were increased among patients who had not previously received 
opioids and received treatment from high-intensity opioid prescribers” (Barnet, Olenski, & 
Anupman, 2017, p. 663). In fact, some studies estimate that almost sixty percent of opioids being 
abused come from a physician prescription, either directly or indirectly (Lembke, 2016). 
Furthermore, it is important to note that increasing addiction rates correspond to an increase in 
pharmaceutical opioid sales (Hahn, 2011). This information demonstrates that as providers write 
more opioid prescriptions, rates of opioid abuse increase. Finally, we must note that, the majority 
of heroin users today began by misusing prescription opioids (NCASA, 2017). 
This problem is exacerbated by a few factors. First, many providers recognize addiction 
but do not know how to treat it (Lembke, 2016). Second, many providers underutilize current 
prevention strategies. For example, while nurse practitioners wrote over 4,000,000 prescriptions 
for opioids in 2013 (Chen, Humphrey, Shah, & Lembke, 2015), only about 20.9% of family 
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nurse practitioners utilized formal screening devices for opioid abuse in their patients 
(Chaudhary, & Compton, 2017).   
Many recommendations for dealing with the opioid epidemic have been proposed. While 
numerous patient/user based initiatives exist, this paper will focus on behavioral changes on the 
part of prescribers of opioids due to the fact that “the misuse of prescription opioids precedes the 
use of heroin and other illicit opioids in the majority of cases” (NCASA, 2017, p.17).  Some of 
the most widely recommended prescriber-centered strategies include: the use of prescription 
drug monitoring programs, changes in prescribing guidelines, prescriber continuing education, 
and substance abuse screening tools. 
With so many recommendations for combating the opioid crisis, providers and healthcare 
systems might not know where to start. According to Hahn (2011), many of the recommended 
strategies have not been fully evaluated for efficacy nor broadly implemented. This has caused a 
knowledge gap regarding best practice. An integrative literature review could gather and analyze 
data with the intention of recommending one or two strategies that have higher efficacy rates. 
This data could then be used to help providers and healthcare systems invest resources in 
evidence-based strategies to reduce opioid addiction.  
This integrative literature review aims to better understand different prescriber-based 
opioid prevention strategies, providing an analysis and ranking for the strategies that most 
effectively reduce opioid abuse and exposure. Additionally, the analysis will provide 
recommendations for future research.  
 To better understand which opioid prevention strategy has the most efficacy, the 
following research question will guide this integrative literature review: Which prescriber-based 
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opioid prevention strategy most effectively reduces opioid abuse? For the purposes of this study, 
effective reduction in opioid abuse is defined as a decrease in: “significant negative 
consequences of using opioids recurrently” (Hahn & Cataldo, 2012, p.1).  
Conceptual Framework 
 
 This study draws on Nola Pender’s health promotion conceptual framework for guidance. 
Nola Pender’s health promotion model explores “the complex biopsychosocial processes that 
motivate individuals to engage in behaviors directed toward the enhancement of health” 
(Murdaugh, Parsons, & Pender, 2002, p. 60). Pender’s framework maintains two theoretical 
foundations: 1.) behavior is rational and economical, and 2.) the environment, personal factors 
and behavior all shape one another (Murdaugh, Parsons, & Pender, 2002, p. 62). There are 
various assumptions that Pender states in her conceptual framework, but there are three 
assumptions particularly relevant to this integrative literature review. First, people want to 
express their full health potential. Second, people are highly affected by healthcare professionals. 
Finally, people change their environment and their environment changes them.  
Pender’s assumption that patients want to express their full health potential gives 
researchers a starting point. If we assume that patients want to express their full health potential, 
we can assume they want to prevent opioid addiction, as this would diminish health potential. 
Then the question “how?” may be asked. Drawing from the model for further guidance, we know 
that people are both affected by their environment and by healthcare professionals. This moves 
us to study prescriber-based prevention strategies because we know that providers not only form 
part of the patient’s environment, but affect the patients directly. Thus, prescriber-based 
prevention strategies and health promotion have the potential to reduce opioid addiction.  
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Finally, researchers can use Nola Pender’s Health Promotion model “to provide a coherent and 
organized framework for intervening with clients to increase health promoting behaviors” 
(Murdaugh, Parsons, & Pender, 2002, p.75). 
Figure 1 Visual Depiction of Nola Pender’s Health Promotion model 
 
 
 
 
Methods 
Design 
 
This research utilized an integrative literature review design for various reasons. First, 
integrative literature reviews, among many things, help identify gaps in knowledge, bridge 
related areas of work and help determine relevant areas for future research (Russell, 2016). This 
particularly relates to prescriber-based opioid prevention strategies because information about 
each individual prevention strategy is available, but current research lacks a comparison to 
determine best practice. This integrative literature review synthesized information about three 
prescriber-based opioid addiction prevention strategies: prescription drug monitoring programs, 
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risk assessment screening tools, and prescriber continuing education. Prescription drug 
monitoring programs store information about patients, providers, prescriptions, pharmacies and 
other information such as medication date dispensed, type and strength (Ringwalt et al., 2015). 
Risk assessment screening tools vary depending on the type. Generally, patients provide 
information that will in turn indicate how many risk factors they have that predispose them to 
opioid addiction. Providers then use this information to guide their prescribing practices. 
Prescriber continuing education includes any workshops or training aimed to educate providers 
on opioids and risks associated with opioid prescriptions. Using a side-by-side comparison of 
each strategy enabled interested parties to determine the best strategy and identify areas that 
require further research.  
Literature Search Strategies 
 
Multiple databases contributed information to this integrative literature review. A 
separate search was conducted for each prevention strategy, utilizing two databases to gather 
results for each strategy. For prescriber continuing education, queries were completed in PubMed 
and Cumulative Index to Nursing and Allied Health Literature (CINAHL) complete. PubMed 
and CINAHL were used to obtain information on prescription drug monitoring programs. 
Finally, PubMed, and ProQuest Nursing, and Allied Health Database were searched to find 
information about risk assessment screening tools.  
 Search terms varied for each separate prevention strategy. Search terms for prescriber 
continuing education included: opioid abuse prevention OR opioid addiction prevention AND 
prescriber education OR continuing education OR physician training OR physician education. 
For the risk assessment screening tool search, terms included: opioid addiction prevention OR 
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opioid abuse prevention AND risk assessment screening tool OR risk assessment questionnaire. 
For the inquiry on prescription drug monitoring programs, the following were terms included in 
the search: opioid abuse prevention OR opioid addiction prevention, AND prescription drug 
monitoring program OR prescription drug program OR pdmp AND effectiveness OR efficacy 
OR result. 
Literature Inclusion/Exclusion Criteria and Data Screening 
 
 For this integrative literature review, the main inclusion criteria were: 1) the primary 
focus of the abstract related to opioid addiction prevention, 2) the article focused on one of the 
three aforementioned prevention strategies, and 3) the article was a primary source. Additionally, 
articles must have been published in the last five years, be peer reviewed, be published in 
English, and have human subjects. Research was excluded based on information in the abstract 
or title if it: 1) did not conduct an intervention with measurable results, and 2) presented an 
intervention for addiction to substances other than opioids (see figure 1, figure 2, & figure 3). 
Data Analysis 
 
 Information extracted from the selected studies in this integrative literature review 
included: author information, purpose statement, research question, information about the sample 
(including demographics and sample size), method, prevention strategy and results of the study. 
The selected studies were organized into separate tables according to the specific prescriber-
based prevention strategy. Table 1 summarizes information about the studies involving 
prescription drug monitoring programs. Table 2 summarizes information about the studies 
involving risk assessment screening tools and table 3 summarizes information from the studies 
involving prescriber continuing education. 
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 The data summarized in the tables provides information about each individual strategy, 
allowing for a side by side comparison. As such, strategies were assessed for efficacy and 
ultimately, ranked, providing information about which method is most effective in preventing 
opioid addiction.  
Results 
 
This integrative literature review includes thirteen articles, each selected to help determine 
which prescriber-based opioid prevention strategy most effectively reduces opioid abuse. Of the 
thirteen articles included in this review, five articles assessed the efficacy of prescription drug 
monitoring programs, four articles measured the results of risk assessment screening tools and 
four articles evaluated the efficacy of prescriber continuing education.  
Prescription Drug Monitoring Programs 
 Prescription drug monitoring programs (PDMPs) have four effects on the opioid 
epidemic. First and foremost, prescription drug monitoring programs result in a statistically 
significant reduction in prescribing and overall use of opioids. Alexander et al. (2016) showed 
that the implementation of a PDMP in the state of Florida (as compared to the control state of 
Georgia) decreased opioid prescriptions by 1.4%, decreased opioid volume by 2.5% and 
decreased the morphine milligram equivalent by 5.6%. The Reisman, Shenoy, Atherly, & 
Flowers (2009) research yielded similar results. They looked at states with active and stable 
PDMPs between the years 1997-2003. Because oxycodone use correlates highly with opioid 
abuse (compared to morphine or hydrocodone) they focused on rates of oxycodone prescription. 
Their research showed that states with PDMPs saw lower rates of oxycodone prescription and 
lower correlating rates of prescription opioid abuse admissions to hospitals.   
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Second, PDMPs impact prescribing/dispensing behaviors. Norwood & Wright (2016) 
used a cross sectional study to analyze whether the use of a PDMP would impact pharmacist 
dispensing patterns. Their paper demonstrated that consistent use of PDMPs made a change in 
dispensation practice 6.4 times more likely and refusal of dispensation 3.3 times more likely. 
Additionally, the Indiana state annual rate of refused dispensation increased from 7 to 25. 
Furthermore, Alexander et al. (2016) showed that the providers most impacted by using PDMPs 
were those with the highest baseline prescribing patterns.  
Third, PDMPs can be used to assess addiction in patients and better understand which 
patients run the risk of high exposure to prescription opioids. Individuals with mental health 
issues often have a dual diagnosis (of substance abuse and a mental health disorder), thus, the 
opioid epidemic affects these individuals disproportionately. Using a PDMP, Hackman et al. 
(2015) found that 57% of patients receiving care at a mental health clinic in Indiana received a 
prescription for opioids. This number far exceeds the average number of individuals receiving 
opioid prescriptions nationwide. Additionally, they found that a higher number of prescriptions 
per patient significantly increased the odds of an opioid dependence diagnosis.  
Finally, PDMPs have successfully demonstrated a correlation between high risk 
prescribers and patient overdoses. Ringwalt et. al (2015) utilized death records in conjunction 
with a PDMP to establish a connection between aberrant prescribing practices and opioid 
overdoses. Their research showed that overdoses often resulted from providers who prescribed: 
“(1)benzodiazepines in conjunction with high levels (100 MMEs) of opioids, (2) opioids 
regardless of dose, (3) high level opioids, and (4) benzodiazepines” (Ringwalt et. al, 2015, 
pg.293).   
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Risk Assessment Screening Tools 
 All four articles that evaluated risk assessment screening tools concluded that they 
demonstrate a strong ability to predict, identify and potentially mitigate the risk of opioid abuse. 
Aldridge, Linford, & Bray (2017) showed that using the Screening, Brief Intervention Referral to 
Treatment (SBIRT) tool reduced illicit drug use by 78.5%. While the tool used in the article by 
Barclay, Owens, & Blackhall (2014) differed from the SBIRT, it demonstrated similarly striking 
results. Barclay, Owens, & Blackhall (2014) analyzed the Opioid Risk Tool (ORT). The ORT 
showed that high risk scores from the screening tool strongly predicted abnormal urine drug 
screens.  For example, only 7% of people who scored low on the ORT had abnormal drug tests 
as compared to the 62.5% of people who scored high on the ORT with abnormal drug test. Olivia 
et al. (2017) found that using applied informatics, STORM (a screening tool) could predict 50% 
of the patients that could potentially have an overdose or drug related suicide event in a given 
year.  
Prescriber Continuing Education 
 Three of the four articles that evaluated prescriber continuing education concluded that it 
yielded little to no statistically significant effect on opioid prescribing rates. Holliday et al. 
(2017) showed that some providers demonstrated an initial decrease in opioid prescribing but 
that those decreases were not sustained. Kahan et al. (2013) determined that continuing 
education had no effect on initial nor long term prescribing rates. The research published by 
Osborn, Yu, Vasilyadis, Craig, & Blackmore (2017) was an exception, showing a significant 
reduction in prescribing rates. This study combined a mandated department wide policy change 
in opioid prescribing (based on the Washington E.D. Opioid Abuse Work Group guidelines) with 
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a continuing education. Prescribers were taught the new guidelines and researchers then looked 
at prescribing rates pre-and post-intervention. Not only did the intervention reduce opioid 
prescriptions by 39% but the reductions were sustained long term.  
Discussion 
 
Findings 
This paper aimed to understand which strategy to decrease opioid addiction would 
produce the greatest reduction in opioid prescribing and/or abuse rates. Based on interpretation 
of the results, the strategies have the greatest to the least impact in the following order: 1) risk 
assessment screening tools 2) prescription drug monitoring programs, and 3) prescriber 
continuing education.  
Risk assessment screening tools showed the most promise in combating the opioid 
epidemic as all four articles that looked at this intervention strategy reported statistically 
significant outcomes. One study showed reductions as high as 78.5% in substance abuse. 
Another study showed a significant correlation between high risk scores on an opioid risk 
screening tool and subsequent abnormal drug screens. Two studies didn’t report a direct 
reduction in opioid abuse, however, they demonstrated a strong ability to predict which patients 
were susceptible to opioid abuse. With this knowledge, providers could alter prescribing 
practices and make treatment referrals accordingly, ultimately reducing opioid abuse.  
One limitation to drawing definitive conclusions regarding the efficacy of risk assessment 
screening tools is that each study used different screening tools. At least three different risk 
assessment screening tools (STORM, ORT, and SBIRT) were used by the researchers. Each of 
these screening tools produced different results, so while overall, we know that screening tools 
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have produced successful outcomes, we do not know what accounts for the differences between 
the outcomes. Did STORM as a screening tool outperform the ORT or was the study that utilized 
STORM designed better? Using a standardized screening tool could strengthen this research and 
allow for easy replication. 
Prescription drug monitoring programs showed a smaller direct impact on opioid abuse 
than risk assessment screening tools. Decreases in opioid use were more modest using PDMPs, 
with some figures only as high as about 5%. However, PDMPs can help indicate which providers 
have risky prescribing practices. Providers with risky prescribing practices can greatly increase 
the risk of opioid dependence and overdose. Ringwalt et. al (2015) demonstrated that between 
30-45% of providers with the riskiest prescribing patterns had prescribed an opioid analgesic to a 
patient within 30 days of his or her death. Additionally, PDMPs can be used to flag patient at risk 
for multiple opioid prescriptions. While PDMPs suggest more modest outcomes in relation to 
direct opioid abuse reduction, their other benefits probably indirectly reduce opioid abuse 
substantially.  
PDMP results had limitations as well. Studies did not use consistent subjects in their 
interventions. Looking at the five articles examining PDMPs, two articles used states as their 
subjects. One article examined multiple states pre-and post-implementation of a PDMP, and the 
other examined one state using a PDMP (Florida)  against a control state (Georgia). The other 
articles evaluated the efficacy of using a PDMP but varied their subjects (pharmacists, patients 
with dual diagnoses, etc). 
Prescriber education, although seeming to have little impact on opioid addiction, can be 
effective when combined with a mandated policy change. Osborn, Yu, Vasilyadis, Craig, & 
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Blackmore (2017) showed that by using recommended guidelines to mandate a policy change 
department wide in an E.D., they reduced opioid prescriptions by 39% in that E.D. The state of 
Ohio saw similar results after creating policy changes surrounding opioid prescribing. According 
to Penm et al. (2017), the governor of Ohio created the Governor’s Cabinet Opiate Action Team 
(GCOAT) in 2011, which had three goals: 1) to promote the responsible use of opioids, 2) to 
reduce the supply of opioids, and 3) to support overdose prevention and expand access to 
naloxone. In order to achieve this goal, they released prescribing guidelines encouraging 
practitioners to consider non-opioid therapies first. In 2015, four years after implementing these 
guidelines, the state of Ohio saw 81 million fewer doses of opioids dispensed than in 2011 
(Penm et al., 2017).  
Limitations 
The lack of evidence based research on opioid prevention strategies limited the scope of 
this paper substantially and represents the largest barrier to formulating concrete solutions to the 
opioid epidemic. Even finding thirteen articles that fit within the search criteria proved to be 
difficult. A larger pool of relevant literature would strengthen this integrative literature review. 
As discussed in the findings section, another barrier of this integrative literature review 
was the lack of consistency in subjects and study design. This was further complicated by the 
fact that within each category of prevention strategy, interventions varied significantly. This 
made standardizing the results into an average percentage for each overall strategy impossible.  
Nursing Implications 
 
 This integrative literature review identifies a critical knowledge gap that needs to be 
researched in order to effectively combat the opioid crisis. Emergency department nurses and 
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psychiatric nurses occupy a particularly relevant position in that they have the most contact with 
patients who abuse opioids. This gives these nurses specialized knowledge and the ability to 
conduct research on the topic given the frequency of their contact with this population. As nurses 
strive to increase their participation in research, this presents an opportunity for nurses to 
conduct research in an urgently needed area. 
 This research also carries the implication of advocacy. Based on the finding of this 
integrative literature review, utilizing PDMPs, screening tools, and mandated policy changes 
surrounding the prescribing of opioids all suggest the ability to decrease opioid abuse. To best 
support patients, nurses must advocate for policies that will decrease negative outcomes, such as 
those listed above.  
Recommendations for Future Research 
 
At this point, people understand the gravity of the opioid epidemic but don’t seem to have 
concrete solutions to combat it. In conducting research for this paper, it became clear that 
evidence based research to support the use of a specific strategy to combat the opioid epidemic is 
lacking. Considering that risk assessment screening tools and using mandated prescribing policy 
changes showed promising results, these strategies require further investigation on a larger scale. 
Osborn, Yu, Vasilyadis, Craig, & Blackmore (2017) saw great outcomes from their study on 
prescriber continuing education combined with mandated policy change. That study used only a 
single hospital emergency department. Replicating this study on a larger scale, by using two 
cities of comparable size and demographics, could substantiate the use of that specific strategy. 
For example, San Antonio and Austin have very similar demographics and a relatively similar 
population size. San Antonio could implement a policy city-wide that all prescribers must use a 
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screening tool before prescribing opioids to all patients and implement guidelines on prescribing 
such as those used in the aforementioned study. Pre-and post-policy prescribing for both cities 
could then be compared to analyze this strategy on a larger scale. 
Conclusion 
 
This paper operates within the framework of Nola Pender’s Health Promotion, 
specifically under the assumption that health professionals can greatly affect their patients. As 
such, recommendations to combat the opioid crisis are directed toward changes in prescriber 
behavior as opposed to patient behavior. Opioid risk assessment screening tools and mandated 
policy changes for opioid prescribing practices show great promise to decrease the epidemic of 
opioid abuse sweeping across the U.S.  
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Appendix 
 
Figure 1. Flow chart of study selection for prescriber continuing education.  
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Figure 2. Flow chart of study selection for prescription drug monitoring programs. 
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Figure 3. Flow chart of study selection for risk assessment screening tools. 
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Data Tables 
 
Table 1 
Summary of studies on the efficacy of prescription drug monitoring programs. 
Reference Purpose Research 
Question 
Sample Method Prevention 
Strategy 
Results 
 
Alexander et 
al. 
(2016) 
To quantify the effect 
of 
Florida's PDMP and 
pill mill laws on 
overall and high-
risk opioid prescribin
g and use. 
 
Will the use of a 
PDMP decrease 
opioid prescribing 
and/ or use? 
Cohort of 
prescribers, retail 
pharmacies and 
patients in Florida 
(compared to 
control state 
Georgia) 
Measured total opioid 
volume, mean morphine 
milligram equivalent 
(MME) per transaction 
and mean days’ supply 
per transaction 
Prescription 
drug 
monitoring 
program 
Resulted in a modest 
decrease in prescribing and 
use. Largest decrease in 
prescribers and users with 
highest baseline prescribing 
and use. 1.4% decrease in 
opioid prescriptions, 2.5% 
decrease in opioid volume, 
5.6% in MME per transaction 
Hackman et 
al. 
(2014) 
To better understand 
the link between 
patients receiving 
dual diagnosis 
(mental health and 
substance abuse) 
treatment and prior 
opioid prescriptions 
using a PDMP. 
Do patients 
receiving 
treatment for a 
dual diagnosis 
have a history of 
receiving opioid 
prescriptions 
within the last 
year? 
Patients in an 
Indiana-based  
community 
mental health 
center, receiving 
treatment for a 
dual diagnosis. 
N= 201 
Double blind evaluation 
compiling information 
for a 12-month period. 
Researchers gathered 
data from the mental 
health clinic’s electronic 
records while also 
gathering data from the 
Indiana PDMP. 
Prescription 
drug 
monitoring 
program 
PDMPs can be used to assess 
high exposure to prescription 
opioids. Especially 
considering most patients in 
the study had been prescribed 
opioids within the last year, 
many with a benzo 
simultaneously prescribed. 
 
Norwood & 
Wright 
(2016) 
Examine how the 
integration and 
consistent use of a 
PDMP in 
pharmacy practice 
impacts pharmacists’ 
dispensing practices 
related to CSPs. 
 
Will the 
integration of 
PDMPs in 
pharmacy practice 
improve a 
pharmacist’s 
ability to make 
informed clinical 
decisions and 
exercise sound 
professional 
judgment? 
 
 
Pharmacists in the 
state of Indiana. 
The sample 
accurately 
represents the 
pharmacist 
workforce with 
regards to age, 
experience and 
gender. N= 1,582 
Cross sectional study 
conducted through a 
study sent to over 10,000 
pharmacists in Indiana 
state. The study 
measured three outcome 
variables: (1) 
dispensation change, (2) 
refused dispensations, (3) 
and annual refusals. 
 
Prescription 
drug 
monitoring 
program 
May improve a pharmacist’s 
ability to make 
informed clinical decisions 
and exercise sound 
professional judgment. 
Dispensation change was 6.4 
times more likely. Refused 
dispensations were 3.3 more 
likely with use of PDMP. 
Annual refusals for providers 
using PDMP were about 25 
compared to 7. 
COMPARISON OF OPIOID ADDICTION PREVENTION STRATEGIES 
 
27 
 
Reisman, 
Shenoy, 
Atherly, & 
Flowers 
(2009) 
Examine the link 
between state medical 
shipments of 
prescription opioids 
and prescription 
opioid 
abuse admissions. 
Evaluate efficacy of 
PDMPs. 
Do PDMP 
decrease amount 
of oxycodone 
shipment and/or 
prescription 
opioid abuse 
admissions? 
States with active 
and stable PDMPs 
during the years 
1997-2003. These 
states included: 
CA, HI, IL, IND, 
MA, MI, NY, 
OK, TX, ID, KY, 
NV, RI, 
& UT. 
Retrospective ecological 
cohort study that 
compares state 
prescription opioid 
shipments for medical 
use and abuse admissions 
for prescription opioids. 
Prescription 
drug 
monitoring 
program 
States with PDMPs saw 
lower rates of opioid 
(oxycodone) shipments and 
prescription opioid abuse 
admissions. Furthermore, 
patients admitted to drug 
rehab in PDMP states were 
usually not there for 
prescription opioids. 
Ringwalt et 
al. 
(2015) 
Use metrics and 
PDMP to identify 
prescribers with 
unusual or 
uncustomary 
prescribing practices 
 
Do providers who 
over-prescribe 
controlled 
substances 
contribute to the 
opioid epidemic? 
Providers 
registered in the 
North Carolina 
Prescription Drug 
Monitoring 
Program. 
Researchers used death 
records from the state's 
vital records database 
and linked them with 
providers who wrote 
prescriptions to patients 
who then died of a 
medication or drug 
overdose within 30 days 
 
Prescription 
drug 
monitoring 
program 
High correlation between 
prescribers of controlled 
substances, who co-
prescribed benzodiazepines 
and high levels of opioid 
analgesics to their patients 
and patient overdose/ death. 
 
 
Table 2 
Summary of studies on the efficacy of risk assessment screening tools. 
Reference Purpose Research 
Question 
Sample Method Prevention 
Strategy 
Results 
Aldrige, 
Linford, & 
Bray 
(2017) 
Compare substance use 
behaviors before 
completing a screening 
tool and after to assess 
for differences. Also to 
provide some criticism 
for a previously 
conducted study about 
screening tools. 
Will utilizing a 
Screening, Brief 
Intervention 
Referral to 
Treatment 
(SBIRT) tool 
change 
substance use 
behaviors when 
analyzed before 
and after 
completion? 
Patients utilizing 
providers who 
received the US 
Substance Abuse 
and Mental 
Health Services 
Administration 
(SAMHSA) grant 
to implement 
SBIRT in 
practice. 
N= 17,575 
patients with 
Organizations using the 
SBIRT provided data for 
patients with substance 
abuse. Pre-SBIRT and 6-
months post-SBIRT data 
was collected and 
compared for 17,575 
patients. 
Risk 
Assessment 
Screening 
Tool 
Significant decreases in 
substance abuse were found 
in post-SBIRT patient data. 
Illicit drug use decreased by 
75.8%. Furthermore, the 
intensity of the intervention 
has a proportionate 
relationship with success of 
substance abuse prevention. 
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substance abuse. 
Barclay, 
Owens, & 
Blackhall 
(2014) 
To assess whether risk 
factors for substance 
abuse could predict 
abnormal urinalysis 
results. 
Do risk factors 
indicated in the 
Opioid Risk 
Tool predict 
subsequent 
abnormalities in 
drug urine 
panels amongst 
cancer patients 
receiving 
palliative care? 
Cancer patients at 
the University of 
Virginia palliative 
care clinic, 
receiving care in 
the month of 
September, 2012. 
N=114 
Electronic medical records 
of patients were analyzed 
to compute an Opioid Risk 
Tool (ORT) score and 
scores were recorded. OPT 
scores were then 
compared to results of 
urine drug screens to 
examine any correlation 
between a predicted high 
risk and abnormal drug 
screen. 
Risk 
Assessment 
Screening 
Tool 
High risk scores from the 
OPT strongly predicted 
abnormal urine drug screens. 
Only 7% of people who 
scored low-risk on the OPT 
had abnormal drug test 
results. However, 62.5% 
percent of people who 
received medium-high risk 
scores had abnormalities in 
their drug screen. 
Bogdanowicz 
et al. 
(2016) 
To examine the efficacy 
of addiction-specific risk 
screenings in predicting 
high mortality risk 
groups. 
Do addiction 
specific brief 
risk screening 
tools effectively 
identify high 
mortality risk 
groups? 
Inhabitants of 
South London 
and Maudsley, 
that were 
identified as 
having an opioid 
use disorder 
(OUD). Patients 
were identified 
during the time 
period between 
April, 2008 to 
31st March, 2014. 
N=4,488 
Patient with an OUD were 
identified in the case 
register database. 
Information for each 
patient was used to 
complete a risk assessment 
on them. After completing 
this data, death certificates 
were searched in the 
Office for National 
Statistics General Records 
Office 
to see if any of these 
patients had died of an 
overdose. 
Risk 
Assessment 
Screening 
Tool 
“Diagnosis-specific brief 
risk screening can identify 
OUD patient subgroups at 
increased risk of all-cause 
and overdose mortality.” 
 
 
Oliva et al. 
(2017) 
To analyze opioid abuse 
risk factors and 
mitigation practices by 
using the Stratification 
Tool for Opioid 
Mitigation Risk 
(STORM) 
Does STORM 
accurately 
indicate and 
prioritize 
patients that 
display opioid 
abuse risk 
factors? 
Patients utilizing 
the VHA who 
received a 
prescription for 
opioids during 
the 2010 fiscal 
year. N= 
1,135,601 
 
Use electronic medical 
records from the VHA to 
estimate risk. STORM risk 
factors include: 
demographics, previous 
overdose/suicide 
information, prescription 
strength and concurrent 
sedative medications, 
substance abuse and 
mental health disorders. 
This information was used 
Risk 
Assessment 
Screening 
Tool 
STORM analysis results 
indicate that informatics can 
be successfully used to 
identify and mitigate the risk 
of opioid abuse and/or 
overdose. “For example, the 
mean risk 
score among the 1,000 
patients with the highest risk 
scores was 
57.9 with 53.7% 
(approximately 1 out of 
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to calculate patient scores. every 2 patients in this 
group having an overdose or 
suicide related event)” 
 
 
Table 3 
Summary of studies on the efficacy of prescriber continuing education. 
Reference Purpose Research 
Question 
Sample Method Prevention 
Strategy 
Results 
Holliday et 
al. 
(2017) 
To fill current 
knowledge gap: 
objectively 
analyze the 
effect of 
education for 
pain 
management on 
opioid 
prescribing 
rates. 
Will providing 
education about 
pain management 
to physicians 
affect “real-world 
practice behavior” 
of prescribing 
opioids? 
Registrars (the 
Australian 
equivalent to 
medical residents) in 
5 regional training 
providers (RTP). 
One RTP was the 
experimental group 
that received the 
training and the 
other 4 RTPs were 
the control. N=849. 
Of the 849, 42 
received the 
training. 
 
A nonequivalent control 
group design nested within an 
ongoing cohort study was 
used. A training workshop 
was provided to all registrars 
in a single regional training 
center. After the training, 
opioid prescriptions were 
monitored to assess for 
changes as compared to the 
control group. The control 
group was comprised of 
registrars at different regional 
training centers that did not 
receive the educational 
training. 
Prescriber 
continuing 
education 
No significant effect on 
opioid prescribing rates after 
providers completed 
continuing education 
compared to control groups. 
There was a slight decrease 
in initial opioid 
prescriptions after the 
training but the training 
failed to increase overall 
opioid cessation.  
Kahan et al. 
(2013) 
To evaluate 
whether a two-
day intensive 
course on 
opioid 
prescribing 
effectively 
reduces the 
amount of 
opioid 
prescriptions 
written by 
providers.  
Will a statistically 
significant effect 
on opioid 
prescribing 
patterns by 
observed after 
providers 
complete a two-
day intensive 
training on opioid 
prescribing? 
Physicians based in 
Ontario that 
complete the two-
day intensive 
training course 
between the years 
2000-2008. 61% 
self-referred, 39% 
referred by the 
College of 
Physicians and 
Surgeons in Ontario 
(CPSO).  N =138. 
Population-based 
retrospective cohort study. 
Physicians who took the 
course were matched with a 
control group of physicians 
who did not take the course. 
The course covered 
information on chronic pain, 
interviewing techniques, 
prescribing, and addiction. 
Using broken-line 
longitudinal regression, total 
amounts of opioids dispensed 
were calculated for both the 
Prescriber 
continuing 
education 
There was not an immediate 
(1 year) nor long term (2 
years) reduction in opioid 
prescribing rate when 
comparing the experimental 
group to the control group. 
One exception to this was 
with the physicians referred 
by the CPSO. This subgroup 
demonstrated a decline in 
opioid prescribing rate to 
young patients in both the 
immediate and long term 
categories.  
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experimental and control 
group. 
Alford, 
Hayes, 
Zisblatt, 
Peloquin, 
Hardesty, & 
White 
(2015) 
To assess the 
efficacy of the 
Safe and 
Competent 
Opioid 
Prescribing 
Education 
(SCOPE of 
Pain) program 
on prescriber 
knowledge, 
attitudes, 
confidence, and 
self-reported 
clinical practice 
in safe opioid 
prescribing. 
Will undergoing 
SCOPE of Pain 
training alter 
provider’s 
knowledge, 
attitude, 
confidence and 
self-reported safe 
opioid prescribing 
patterns? 
Participants who 
completed the 
SCOPE of Pain 
training between the 
years 2013-2014. 
This study focused 
on providers who 
manage chronic pain 
such as physicians, 
physician assistants, 
and nurse 
practitioners. 
N=2,850 (complete 
first two surveys) 
N=476 (completed 
all 3 surveys) 
Participants included in the 
survey completed the Scope 
of Pain training. They 
completed pre, immediate 
post program, and 2 month 
post program self-reported 
quantitative assessment 
surveys. Surveys included 
questions about knowledge, 
confidence, attitude, and 
clinical performance 
(prescribing). Paired t-tests 
were used to establish change 
in clinical practice two 
months after participation. 
Prescriber 
continuing 
education 
The SCOPE “Improved 
clinician-level safe opioid 
prescribing outcomes, 
however, its impact on 
mitigating opioid misuse 
risk and harm while 
maintaining access to 
opioids for those that are or 
would benefit remains an 
unanswered question.” 
 
Osborn, Yu, 
Williams, 
Vasilyadis, 
Craig, & 
Blackmore 
(2017) 
To determine 
how the 
implementation 
of a prescription 
policy for 
opioids effects 
overall opioid 
prescribing 
patterns in an 
emergency 
department 
(ED) . 
Will a 
collaborative staff 
educational 
initiative to train 
ED providers on 
new opioid 
prescribing 
policies have a 
statistically 
significant effect 
on overall opioid 
prescribing 
patterns in the 
hospital ED? 
Patients at an urban, 
non-university, 
teaching hospital in 
the Pacific 
Northwest. 
Participants were 
age 18 and older 
between 2007 and 
2014.  
N= 116,676 
Pre-intervention and post-
intervention time series study 
in which the ED opioid 
prescribing rate was analyzed 
before the education on 
policy change and then after 
using. Policy changes were 
based on the Washington ED 
opioid abuse Work Group 
guidelines. Information about 
prescribing patterns was 
retrieved retrospectively from 
electronic medical records. 
The years 2007-2010 
comprised the pre-
intervention time frame and 
2012-2014 was the post-
intervention time frame. 
Prescriber 
continuing 
education 
The intervention resulted in 
a 39% decrease in patients 
discharged with an opioid 
prescription from the ED. 
Additionally, these changes 
in prescribing patterns were 
sustained when analyzed at a 
2.5 year follow-up.  
 
 
